Prevention of Recurrent C. difficile Infections (CDI) with Antitoxin Antibody Bezlotoxumab

Alex Therien of Merck joined us for Americas Antibody Congress 2016 to discuss ” prevention of recurrent CDIs with antitoxin antibody bezlotoxumab” .

In this presentation learn about Clostridium difficile infections (CDI), why they are a growing concern, and how they can be prevented.

Download this presentation to understand more about:

  • The toxins of C. difficile: TcdA and TcdB
  • CDI pathogenesis and progression
  • Actoxumab and bezlotoxumab: human monoclonal antitoxin antibodies

and much more!

Get your copy here !

If you’re interested in learning more about CDIs and what can prevent them , join us at Americas Antibody Congress 2017 , held May 23-24 in San Diego, CA . This event is co-located with World Biosimilar Congress USA and Cell Culture World Congress USA.

Learn more about Americas Antibody Congress